HAE

Clinical trials for HAE explained in plain language.

Never miss a new study

Get alerted when new HAE trials appear

Sign up with your email to follow new studies for HAE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1 Completed 1

Study offers ongoing HAE treatment access for prior trial participants

Disease control ENROLLING_BY_INVITATION

This study gives people with hereditary angioedema (HAE) who were in earlier berotralstat trials continued access to the medication. About 139 participants will receive the drug and be monitored for side effects and safety. The goal is to keep providing treatment while gathering …

Matched conditions: HAE

Phase: PHASE3 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control

Last updated May 05, 2026 11:53 UTC

HAE

Get alerted when new HAE trials appear

Study offers ongoing HAE treatment access for prior trial participants